<?xml version="1.0" encoding="UTF-8"?>
<ref id="B29-pharmaceuticals-14-00381">
 <label>29.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Claas</surname>
    <given-names>E.C.</given-names>
   </name>
   <name>
    <surname>Osterhaus</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Van Beek</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>De Jong</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Rimmelzwaan</surname>
    <given-names>G.F.</given-names>
   </name>
   <name>
    <surname>Senne</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Krauss</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Shortridge</surname>
    <given-names>K.F.</given-names>
   </name>
   <name>
    <surname>Webster</surname>
    <given-names>R.G.</given-names>
   </name>
  </person-group>
  <article-title>Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus</article-title>
  <source>Lancet</source>
  <year>1998</year>
  <volume>351</volume>
  <fpage>472</fpage>
  <lpage>477</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(97)11212-0</pub-id>
  <pub-id pub-id-type="pmid">9482438</pub-id>
 </element-citation>
</ref>
